Literature DB >> 3322367

Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study.

S C Robson1, S Hunter, M Moore, W Dunlop.   

Abstract

Serial haemodynamic investigations were performed in 15 women at 38 weeks gestation and then 2, 6, 12 and 24 weeks after delivery. Cardiac output was measured by Doppler and cross-sectional echocardiography at the aortic, pulmonary and mitral valves. Cardiac chamber size and ventricular function were investigated by M-mode echocardiography. Flow measurements at the three intracardiac sites correlated closely. Cardiac output fell from a mean of 7.42 l/min at 38 weeks to 4.96 l/min at 24 weeks after delivery, a fall of 33%. Most of this decrease (28%) had occurred by 2 weeks. This was associated with a 20% reduction in heart rate and an 18% reduction in stroke volume. By 2 weeks after delivery there was a significant decrease in left atrial dimension and left ventricular end-diastolic dimension. Left ventricular wall thickness and mass declined throughout the period of study as did aortic, pulmonary and mitral valve areas. M-mode derived indices of myocardial contractility were all significantly reduced by 2 weeks and thereafter showed no further change. No haemodynamic differences were found between lactating and non-lactating mothers.

Entities:  

Mesh:

Year:  1987        PMID: 3322367     DOI: 10.1111/j.1471-0528.1987.tb02286.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  22 in total

Review 1.  Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.

Authors:  André Dallmann; Ibrahim Ince; Michaela Meyer; Stefan Willmann; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-11       Impact factor: 6.447

Review 2.  The Role of Cardiac Biomarkers in Pregnancy.

Authors:  Emily S Lau; Amy Sarma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

Review 3.  Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.

Authors:  Ki Park; Janet Wei; Margo Minissian; C Noel Bairey Merz; Carl J Pepine
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

Review 4.  Anatomical and physiological alterations of pregnancy.

Authors:  Jamil M Kazma; John van den Anker; Karel Allegaert; André Dallmann; Homa K Ahmadzia
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-06       Impact factor: 2.745

Review 5.  Pregnancy as a cardiac stress model.

Authors:  Eunhee Chung; Leslie A Leinwand
Journal:  Cardiovasc Res       Date:  2014-01-20       Impact factor: 10.787

Review 6.  Pregnancy in Women with Congenital Heart Disease.

Authors:  Evin Yucel; Doreen DeFaria Yeh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08-22

Review 7.  Pregnancy in women with valvular heart disease.

Authors:  Karen K Stout; Catherine M Otto
Journal:  Heart       Date:  2006-08-11       Impact factor: 5.994

Review 8.  Atrial fibrillation during pregnancy: a 9-month period with limited options.

Authors:  Konstantinos Iliodromitis; Jacek Kociszewski; Harilaos Bogossian
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-04-06

9.  Optimal pacing modes after cardiac transplantation: is synchronisation of recipient and donor atria beneficial?

Authors:  G Parry; K Malbut; J H Dark; R S Bexton
Journal:  Br Heart J       Date:  1992-08

10.  Atrial natriuretic factor release during pregnancy in rats.

Authors:  Y Zhang; K Novak; S Kaufman
Journal:  J Physiol       Date:  1995-10-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.